Fairmount Funds Management LLC 13D and 13G filings for Trevi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:48 pm Sale | 2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Fairmount Funds Management LLC | 0 0.000% | -6,018,465 (Position Closed) | Filing |
| 2023-02-14 3:45 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Fairmount Funds Management LLC | 6,018,465 9.900% | 2,258,955 (+60.09%) | Filing |
| 2022-04-21 10:00 am Purchase | 2022-04-11 | 13G | Trevi Therapeutics, Inc. TRVI | Fairmount Funds Management LLC | 3,759,510 9.900% | 3,759,510 (New Position) | Filing |